News Focus
News Focus
Post# of 257262
Next 10
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 207635

Wednesday, 01/11/2017 9:53:17 AM

Wednesday, January 11, 2017 9:53:17 AM

Post# of 257262
MNTA—Clarification of dual opt-in options in CSL deal:

#msg-127780821

The dual opt-in options make for an unusual deal structure, but they give MNTA the financial flexibility it sought in light of the unknown near-term revenue stream from 40mg Copaxone.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now